The idiopathic Intracranial Hypertension Treatment Trial was the first randomized double-masked placebo controlled trial for the management of IIH. The results of the study have given us additional insight to this disease as well as enabled us to better manage patients with new treatment strategies.

Advanced in clinical and bench research in ophthalmology has produced multiple new treatment options for a variety of ocular diseases.  New technology, including the fast growing field of ocular imaging, is been used to further understand eye anatomy and pathology.  Progress in the field of ocular surgery has introduced new techniques and better outcomes.  The clinical and research environment is complex; issues related to ethics, quality improvement and new technology affect all eye care providers. The Eye Institute has, as one of its mission, the goal of being at the forefront of research, clinical care and education.  Our goal is to educate the academic and community eye care providers, residents, researchers and medical students on the best and newest clinical and surgical treatments, cutting edge research and important non-clinical topics available in the field.